High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

Mostrar outras versões (1)

Detalhes bibliográficos
Principais autores:	Boultwood, J, Perry, J, Zaman, R, Fernandez-Santamaria, C, Littlewood, T, Kusec, R, Pellagatti, A, Wang, L, Clark, R, Wainscoat, J
Formato:	Journal article
Publicado em:	2010

Registros relacionados

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
por: Boultwood, J, et al.
Publicado em: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
por: Fernandez-Mercado, M, et al.
Publicado em: (2010)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
por: Boultwood, J, et al.
Publicado em: (2010)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
por: Boultwood, J, et al.
Publicado em: (2009)

The current knowledge on ASXL1-mutated acute myeloid leukemia
por: Marta Andrzejewska, et al.
Publicado em: (2022-02-01)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells
por: Davies, C, et al.
Publicado em: (2013)

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.
por: Davies, C, et al.
Publicado em: (2013)

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value
por: Marta Pratcorona, et al.
Publicado em: (2012-03-01)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.
por: Campbell, L, et al.
Publicado em: (2006)

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
por: Aram Bidikian, et al.
Publicado em: (2022-10-01)

Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells
por: Tadayuki Akagi, et al.
Publicado em: (2009-09-01)

Analysis of telomere length in chronic myelogenous leukemia.
por: Boultwood, J, et al.
Publicado em: (1997)

Analysis or telomere length in chronic myelogenous leukemia
por: Fidler, C, et al.
Publicado em: (1998)

AMPLIFICATION OF MITOCHONDRIAL-DNA IN ACUTE MYELOID-LEUKEMIA
por: Boultwood, J, et al.
Publicado em: (1994)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
por: Boultwood, J, et al.
Publicado em: (1996)

ASXL1/2 mutations and myeloid malignancies
por: Edward A. Medina, et al.
Publicado em: (2022-09-01)

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia
por: Atoyebi, W, et al.
Publicado em: (1997)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
por: Boultwood, J, et al.
Publicado em: (2004)

Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.
por: Fabiola Traina, et al.
Publicado em: (2012-01-01)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
por: Watkins, F, et al.
Publicado em: (2004)

RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
por: Rabindranath Bera, et al.
Publicado em: (2019-10-01)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
por: Yi Fan, et al.
Publicado em: (2021-10-01)

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
por: Boultwood, J, et al.
Publicado em: (1999)

Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies
por: Fernanda Borges da Silva, et al.
Publicado em: (2015-04-01)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
por: Wang, L, et al.
Publicado em: (2008)

Neutrophil gene expression in chronic myeloproliferative disorders.
por: Eagleton, H, et al.
Publicado em: (2003)

ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group
por: Peter Paschka, et al.
Publicado em: (2015-03-01)

Loss of Asxl2 leads to myeloid malignancies in mice
por: Jianping Li, et al.
Publicado em: (2017-06-01)

The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia
por: Teresa D'Altri, et al.
Publicado em: (2020-05-01)

Prognostic significance of ASXL1 mutations in acute myeloid leukemia: A systematic review and meta-analysis
por: Maryam Sheikhi, et al.
Publicado em: (2024-02-01)

Single-nucleotide polymorphism array-based karyotyping of acute promyelocytic leukemia.
por: Inés Gómez-Seguí, et al.
Publicado em: (2014-01-01)

Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
por: Thiago Rodrigo de Noronha, et al.
Publicado em: (2015-02-01)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
por: Li Wang, et al.
Publicado em: (2008-07-01)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
por: Boultwood, J, et al.
Publicado em: (2012)

5q- syndrome.
por: Boultwood, J, et al.
Publicado em: (2012)

Prognosis and risk factors for ASXL1 mutations in patients with newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
por: Liqing Yang, et al.
Publicado em: (2024-01-01)

ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
por: Concepción Prats‐Martín, et al.
Publicado em: (2020-06-01)

THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
por: Enas A Dammag, et al.
Publicado em: (2020-01-01)

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Nur Soyer, et al.
Publicado em: (2017-05-01)

Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis
por: Shuhei Asada, et al.
Publicado em: (2018-07-01)